| Clinical data | |
|---|---|
| Other names | CORT-118335 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C24H23F3N2O2 |
| Molar mass | 428.455 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Miricorilant (CORT-118335) is a small molecule that works as aselective glucocorticoid receptor modulator andmineralcorticoid receptor antagonist.[1][2][3][4] It was developed by Corcept Therapeutics fornonalcoholic steatohepatitis[5] and weight gain associated withatypical antipsychotics.[6]